Practical Matters: Rare Disease Advocates Want Help From US FDA Hub To Make Data Useful

 
• By Bridget Silverman
  
US FDA Rare Disease Innovation Hub is looking for ways to constructively engage the diverse efforts of advocacy groups and agency initiatives (Shutterstock)

More from Rare Diseases

More from Pathways & Standards